4/3
07:25 am
lrmr
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "buy" rating re-affirmed by analysts at Citigroup Inc..
Medium
Report
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "buy" rating re-affirmed by analysts at Citigroup Inc..
3/25
10:18 am
lrmr
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $26.00 price target on the stock.
Low
Report
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $26.00 price target on the stock.
3/25
10:18 am
lrmr
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $26.00 price target on the stock.
Low
Report
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $26.00 price target on the stock.
3/25
10:09 am
lrmr
Rating for LRMR
Low
Report
Rating for LRMR
3/25
10:09 am
lrmr
Rating for LRMR
Low
Report
Rating for LRMR
3/25
07:37 am
lrmr
Rating for LRMR
Low
Report
Rating for LRMR
3/25
07:37 am
lrmr
Rating for LRMR
Low
Report
Rating for LRMR
1/24
08:02 am
lrmr
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Medium
Report
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.